Sonelokimab Meets Primary
Sonelokimab Meets Primary entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.
Timeline
Mon, 10 Aug 2026 16:55:57 GMTMoonLake's sonelokimab meets all endpoints in Phase 3 IZAR-1 psoriatic arthritis trial - Dealroom
Mon, 10 Aug 2026 14:00:21 GMTSonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial - Dermatology Times
Related explainers
Connected entities
FAQ
What does this page track?
Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Sonelokimab Meets Primary.
Why might this page be noindex?
Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.
Where should readers verify facts?
Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.
Source diversity
2 distinct publisher/source names are currently connected to this entity page.